Ident. | Authors (with country if any) | Title |
---|
000029 (2011) |
Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon] | Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma |
000091 (2012) |
Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni] | Interleukin-6 and cytochrome-P450, reason for concern? |
000143 (2012) |
Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France] | Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis |
000457 (2013) |
C. Guillou ; G. Avenel ; C. Derambure ; M. Verdet ; M.-L. Golinski ; M. Hiron ; S. Adriouch ; O. Boyer [France] ; T. Lequerré ; O. Vittecoq | AB0305 Potential in vitro immunomodulatory effects of the recombinant human alpha-enolase on peripheral blood mononuclear cells (pbmcs) from healthy donors. |
000570 (2012) |
Zhifeng Wei [République populaire de Chine] ; Fengyun Wang [République populaire de Chine] ; Jie Song [République populaire de Chine] ; Qian Lu [République populaire de Chine] ; Peng Zhao [République populaire de Chine] ; Yufeng Xia [République populaire de Chine] ; Guixin Chou [République populaire de Chine] ; Zhengtao Wang [République populaire de Chine] ; Yue Dai [République populaire de Chine] | Norisoboldine inhibits the production of interleukin‐6 in fibroblast‐like synoviocytes from adjuvant arthritis rats through PKC/MAPK/NF‐κB‐p65/CREB pathways |
000716 (2013) |
Jayesh Pandya [Suède] ; Mohammad Shahadat Hossain [Suède] ; Ingrid E. Lundberg [Suède] ; Vivianne Malmström [Suède] | A3.11 Immunosuppressive Effects of Glucocorticoids and Regulatory T Cells on CD28null T Cells in Vitro |
000874 (2012) |
Ti Wen [République populaire de Chine] ; Yangguang Li [République populaire de Chine] ; Meng Wu [République populaire de Chine] ; Xiaolin Sun [République populaire de Chine] ; Xiucong Bao [République populaire de Chine] ; Yuquan Lin [République populaire de Chine] ; Jianlei Hao [République populaire de Chine] ; Lin Han [République populaire de Chine] ; Guangchao Cao [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Yuxiu Liu [République populaire de Chine] ; Zhenzhou Wu [République populaire de Chine] ; Zhangyong Hong [République populaire de Chine] ; Puyue Wang [République populaire de Chine] ; Liqing Zhao [République populaire de Chine] ; Zhanguo Li [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] ; Zhinan Yin [République populaire de Chine] | Therapeutic effects of a novel tylophorine analog, NK‐007, on collagen‐induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation |
000886 (2013) |
M. Van Roy [Belgique] ; A. Van De Sompel [Belgique] ; K. De Smet [Belgique] ; J. Jacobs [Belgique] ; T. Denayer [Belgique] ; H. Ulrichts [Belgique] ; J. Baumeister [Belgique] ; J.-B. Holz [Belgique] | FRI0021 Alx-0061, an anti-IL-6r nanobody® for therapeutic use in rheumatoid arthritis, demonstrates in vitro a differential biological activity profile as compared to tocilizumab |
000A69 (2011) |
Babasaheb Bandgar [Inde] ; Baliram Hote [Inde] ; Rahul Gangwal [Inde] ; Abhay Sangamwar [Inde] | Synthesis, biological evaluation, and pharmacokinetic profiling of benzophenone derivatives as tumor necrosis factor-alpha and interleukin-6 inhibitors |
000B27 (2012) |
Jae Kuk Ryu [Corée du Sud] ; Hyo Sun Kim [Corée du Sud] ; Doo Hyun Nam [Corée du Sud] | Current status and perspectives of biopharmaceutical drugs |
000C01 (2015) |
Ka-Heng Lee [Malaisie] ; Faridah Abas [Malaisie] ; Noorjahan Banu Mohamed Alitheen [Malaisie] ; Khozirah Shaari [Malaisie] ; Nordin Haji Lajis [Malaisie] ; Daud Ahmad Israf [Malaisie] ; Ahmad Syahida [Malaisie] | Chemopreventive effects of a curcumin‐like diarylpentanoid [2,6‐bis(2,5‐dimethoxybenzylidene)cyclohexanone] in cellular targets of rheumatoid arthritis in vitro |
000C33 (2013) |
S. Kaneshiro ; K. Ebina ; M. Hirao [Japon] ; J. Hashimoto [Japon] ; K. Shi ; H. Yoshikawa | FRI0054 IL-6 negatively regulates osteoblast differentiation through ERK pathway in vitro |
000C67 (2011) |
Tatsuro Shibui [Japon] ; Teruaki Kobayashi [Japon] | Mimotopes to Cetuximab Isolated by mRNA-Display using Random Peptide Libraries and their Characteristics |
000C72 (2011) |
P. Drastich [République tchèque] ; L. Frolova-Brizova [République tchèque] ; P. Zanvit [République tchèque] ; J. Spicak [République tchèque] ; H. Tlaskalova-Hogenova [République tchèque] | Spontaneous in vitro IL-6 production in various intestinal segments in patients with inflammatory bowel disease |
000D17 (2015) |
Peter G. K. Clark [Royaume-Uni] ; Lucas C. C. Vieira [Royaume-Uni] ; Cynthia Tallant [Royaume-Uni] ; Oleg Fedorov [Royaume-Uni] ; Dean C. Singleton [Royaume-Uni] ; Catherine M. Rogers [Royaume-Uni] ; Octovia P. Monteiro [Royaume-Uni] ; James M. Bennett [Royaume-Uni] ; Roberta Baronio [Royaume-Uni] ; Susanne Müller [Royaume-Uni] ; Danette L. Daniels [États-Unis] ; Jacqui Méndez [États-Unis] ; Stefan Knapp [Royaume-Uni] ; Paul E. Brennan [Royaume-Uni] ; Darren J. Dixon [Royaume-Uni] | LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor |
000D22 (2015) |
Peter G. K. Clark [Royaume-Uni] ; Lucas C. C. Vieira [Royaume-Uni] ; Cynthia Tallant [Royaume-Uni] ; Oleg Fedorov [Royaume-Uni] ; Dean C. Singleton [Royaume-Uni] ; Catherine M. Rogers [Royaume-Uni] ; Octovia P. Monteiro [Royaume-Uni] ; James M. Bennett [Royaume-Uni] ; Roberta Baronio [Royaume-Uni] ; Susanne Müller [Royaume-Uni] ; Danette L. Daniels [États-Unis] ; Jacqui Méndez [États-Unis] ; Stefan Knapp [Royaume-Uni] ; Paul E. Brennan [Royaume-Uni] ; Darren J. Dixon [Royaume-Uni] | LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor |
000D26 (2013) |
A. Matucci [Italie] ; S. Pratesi [Italie] ; G. Petroni [Italie] ; F. Nencini [Italie] ; G. Virgili [Italie] ; M. Milla [Italie] ; E. Maggi [Italie] ; A. Vultaggio [Italie] | Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab |
000E47 (2010) |
Teruaki Kobayashi [Japon] ; Minako Kakui [Japon] ; Tatsuro Shibui [Japon] ; Yasunori Kitano [Japon] | In Vitro Selection of a Peptide Inhibitor of Human IL-6 Using mRNA Display |
000E52 (2011) |
Hidenori Ohnishi [Japon] ; Takahide Teramoto [Japon] ; Hiroaki Iwata [Japon] ; Zenichiro Kato [Japon] ; Takeshi Kimura [Japon] ; Kazuo Kubota [Japon] ; Ryuta Nishikomori [Japon] ; Hideo Kaneko [Japon] ; Mariko Seishima [Japon] ; Naomi Kondo [Japon] | Characterization of NLRP3 Variants in Japanese Cryopyrin-Associated Periodic Syndrome Patients |
000E64 (2013) |
Marvin Rubenstein [États-Unis, Niger] ; Courtney M. P. Hollowell [États-Unis] ; Patrick Guinan [États-Unis] | Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3 |
000E75 (2012) |
Jie Fan [République populaire de Chine] ; Huiting Zhou [République populaire de Chine] ; Shihui Wang [République populaire de Chine] ; Hailian Wang [République populaire de Chine] ; Yushun Zhang [République populaire de Chine] ; Yingtao Guo [République populaire de Chine] ; Qing Li [République populaire de Chine] ; Zhongjun Li [République populaire de Chine] ; Zhihui Zhao [République populaire de Chine] | Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model |